Fausto Palmieri

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

M. Baccarani, G. Rosti, P. Vigneri, 2019, Blood advances.

atreatment of high-risk , Philadelphia-positive chronic myeloid leukemia : Comparison of imatinib 400 mg and 800 mg daily in

M. Baccarani, A. Nagler, G. Rosti, 2009 .

The multi‐tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real‐world data

F. Pane, F. Di Raimondo, G. Specchia, 2020, European journal of haematology.

Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry

R. Latagliata, V. Martinelli, L. Gugliotta, 2009, American journal of hematology/oncology.

Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

M. Baccarani, A. Nagler, G. Rosti, 2008 .

Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.

V. Martinelli, A. Vannucchi, M. Mazzucconi, 2011, Leukemia research.

The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study

A. Risitano, E. Vigna, F. Di Raimondo, 2021, Annals of Hematology.

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.

Giovanni Martinelli, Arnon Nagler, Giovanna Rege-Cambrin, 2009, Blood.

Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT)

G. Gaidano, V. Martinelli, G. Cimino, 2011 .

Differences among young adults, adults and elderly chronic myeloid leukemia patients.

G. Specchia, M. Gobbi, R. Fanin, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.